Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized, Controlled, Double-blind Clinical Trial Comparing the Efficacy and Safety of Chemoprophylaxis With Hydroxychloroquine in Patients Under Biological Treatment and / or JAK Inhibitors in the Prevention of SARS-CoV-2 Infection

NCT04330495 is registered in ClinicalTrials.gov with Instituto de Investigación Marqués de Valdecilla as lead sponsor.

NCT NCT04330495
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04330495 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized, Controlled, Double-blind Clinical Trial Comparing the Efficacy and Safety of Chemoprophylaxis With Hydroxychloroquine in Patients Under Biological Treatment and / or JAK Inhibitors in the Prevention of SARS-CoV-2 Infection
Lead sponsor
Instituto de Investigación Marqués de Valdecilla
Phase
Phase 4
Overall status
Withdrawn
Start date
April 6, 2020
Completion date
August 27, 2021
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

covid 19, immunomediated inflammatory disease in treatment with biological agents and / or jak inhibitors